Myers Squibb Co Bristol

This profile gathers the share dealings of Myers Squibb Co Bristol across 3 companies, led by Inhibitex Inc, Mead Johnson Nutrition Co and Zymogenetics Inc. Between 18 December 2009 and 13 February 2012, the trades on record add up to 5 filings.

None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.

The newest entry dates from 15 February 2012: a transaction of €1.6B, in Inhibitex Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. US insiders must file a Form 4 within two business days of a trade. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.